Canopy Growth Corp (CGC) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.023x

Based on the latest financial reports, Canopy Growth Corp (CGC) has a cash flow conversion efficiency ratio of -0.023x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-17.24 Million) by net assets ($758.17 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Canopy Growth Corp - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Canopy Growth Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Canopy Growth Corp for a breakdown of total debt and financial obligations.

Canopy Growth Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Canopy Growth Corp ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Orthofix Medical Inc
NASDAQ:OFIX
0.063x
Malibu Boats Inc
NASDAQ:MBUU
0.025x
Suzhou Industrial Park Heshun Electric Co Ltd
SHE:300141
-0.022x
CANGO INC. SP.ADR/2 CL.A
F:9C0A
N/A
Hangzhou Prevail Optoelectronic Equipment Co Ltd
SHE:300710
0.022x
Light S.A
SA:LIGT3
-0.019x
Jw Pharmac
KO:001060
0.132x
Westrock Coffee Company
NASDAQ:WEST
0.135x

Annual Cash Flow Conversion Efficiency for Canopy Growth Corp (2010–2025)

The table below shows the annual cash flow conversion efficiency of Canopy Growth Corp from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see Canopy Growth Corp (CGC) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 $487.21 Million $-165.75 Million -0.340x +39.61%
2024-03-31 $500.51 Million $-281.95 Million -0.563x +23.21%
2023-03-31 $760.02 Million $-557.55 Million -0.734x -386.60%
2022-03-31 $3.62 Billion $-545.81 Million -0.151x -17.24%
2021-03-31 $3.62 Billion $-465.73 Million -0.129x +39.46%
2020-03-31 $3.64 Billion $-772.63 Million -0.212x -187.46%
2019-03-31 $7.24 Billion $-535.03 Million -0.074x -12.70%
2018-03-31 $1.24 Billion $-81.51 Million -0.066x -48.75%
2017-03-31 $614.74 Million $-27.09 Million -0.044x +56.17%
2016-03-31 $123.78 Million $-12.45 Million -0.101x +57.28%
2015-03-31 $41.41 Million $-9.75 Million -0.235x +47.67%
2014-12-31 $21.67 Million $-9.75 Million -0.450x -24.76%
2014-03-31 $3.83 Million $-1.38 Million -0.361x -384.28%
2013-03-31 $497.01K $-37.00K -0.074x -114.59%
2012-03-31 $537.65K $-18.65K -0.035x +32.04%
2011-03-31 $556.60K $-28.41K -0.051x -323.60%
2010-03-31 $580.67K $-7.00K -0.012x --

About Canopy Growth Corp

NASDAQ:CGC USA Drug Manufacturers - Specialty & Generic
Market Cap
$477.79 Million
Market Cap Rank
#12763 Global
#2977 in USA
Share Price
$1.13
Change (1 day)
+1.80%
52-Week Range
$0.86 - $1.93
All Time High
$568.90
About

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such… Read more